Popular Articles

St. Jude Medical Announces Australian TGA Regulatory Approval For Libra Deep Brain Stimulation Systems For Parkinson's Disease
St. Jude Medical, Inc. (NYSE:STJ) announced Australian Therapeutic Goods Administration (TGA) approval of its Libra® and LibraXP™ deep brain stimulation (DBS) systems for treating the symptoms of Parkinson"s disease, a neurological disorder that progressively diminishes a person"s control over his or her movements.
diet pills
New Device For Liver Cancer Cleared
Acculis Limited, the UK based specialist microwave ablation company based in Denmead, England, announced the clearance of its latest device for coagulating and killing unwanted tissue during surgery. The device, designed for coagulations at the surface of the tissue fires controlled high power microwave energy into the target area causing it to heat rapidly and the cells to die. Liver surgeons around the world are using the Acculis MTA System to address tumours inside the liver using its existing needle probes that take the microwave energy to the centre of tumours. Using the same control unit, this latest device allows surgeons to address deposits on the surface of the liver without using a needle. David Lloyd, consultant surgeon from Leicester Royal Infirmary, worked with Professor Nigel Cronin on the device which was also used by consultant HPB surgeons Graeme Poston, Liverpool Aintree and David Sherlock, North Manchester General during the development phase under MHRA control.
News of the day
The Johns Hopkins Hospital Tops U.S. News & World Report "Honor Roll" 19th Year In A Row
The Johns Hopkins Hospital has once again -- for the 19th consecutive time -- earned the top spot in U.S. News & World Report"s annual rankings of more than 4,800 American hospitals, placing first in three medical specialties and in the top 16 in 13 others.
Nutrition

H1N1 Influenza: Information For Donors

No Additional Risk The World Health Organization (WHO) has announced a global Influenza A(H1N1) pandemic now that 74 countries have officially reported over 30,000 cases of Influenza A(H1N1) infection. A pandemic has been declared because of the virus" geographical spread. It does not reflect an increase in the severity of the illness. Safety of the blood supply is the number one priority of Canadian Blood Services. At the present time, there is no additional risk to the blood supply requiring extra donor screening measures. There have been no reported cases of transfusion-transmission of respiratory viruses such as influenza to date. These viruses are usually spread by droplets through the respiratory route or by direct contact. It is very important, however that Canadian Blood Services is able to maintain the blood supply for patients who require transfusion. Advice For Donors If you have recently visited Mexico and have a cold, or are otherwise feeling unwell, please wait two weeks before coming to a clinic to donate. For further health information, please consult your physician. Canadian Blood Services Is Prepared Canadian Blood Services is continuing to closely monitor the situation and will provide updated information as necessary. We are working closely with national and international public health authorities. Canadians should rest assured that we have a comprehensive emergency plans that can be implemented rapidly and effectively if the need should arise. Canadian Blood Services" activities to date are consistent with other blood agencies and what they are doing. Our plan positions us well to react to the changing situation and safeguard the security of the blood supply. For info about human swine flu or pandemic influenza, visit: http://www.phac-aspc.gc.ca Canadian Blood Services


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):